Literature DB >> 3308211

Immunological aspects of chronic active hepatitis.

S Vento1, A L Eddleston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3308211      PMCID： PMC1542717     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  62 in total

1.  The HLA system and its relation to disease.

Authors:  H O McDevitt
Journal:  Hosp Pract (Off Ed)       Date:  1985-07-15

2.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

3.  Cell-mediated immune response to hepatitis B antigen in patients with liver disease.

Authors:  M J Gerber; A Phuangsab; S B Vittal; D Dourdourekas; F Steigmann; B F Clowdus
Journal:  Am J Dig Dis       Date:  1974-07

4.  T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease.

Authors:  S Vento; J E Hegarty; A Alberti; C J O'Brien; G J Alexander; A L Eddleston; R Williams
Journal:  Hepatology       Date:  1985 Mar-Apr       Impact factor: 17.425

Review 5.  Autoimmunity in liver disease.

Authors:  I G McFarlane
Journal:  Clin Sci (Lond)       Date:  1984-12       Impact factor: 6.124

Review 6.  Immunologic and genetic factors in autoimmune diseases.

Authors:  Y Shoenfeld; R S Schwartz
Journal:  N Engl J Med       Date:  1984-10-18       Impact factor: 91.245

7.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

8.  Naturally occurring serum antiidiotypic antibody against antiliver-specific membrane lipoprotein in patients with hepatitis.

Authors:  A Tsubouchi; K Yoshioka; S Kakumu
Journal:  Hepatology       Date:  1985 Sep-Oct       Impact factor: 17.425

9.  Interdigitating and dendritic reticulum cells in chronic active hepatitis.

Authors:  K A Bardadin; V J Desmet
Journal:  Histopathology       Date:  1984-07       Impact factor: 5.087

10.  Antigen specific suppressor cell function in autoimmune chronic active hepatitis.

Authors:  S Vento; J E Hegarty; G Bottazzo; E Macchia; R Williams; A L Eddleston
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321
View more
  8 in total

1.  Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.

Authors:  N Custro; G Montalto; V Scafidi; M Soresi; S Gallo; S Tripi; A Notarbartolo
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

2.  Adoptive transfer of experimental autoimmune hepatitis in mice--cellular interaction between donor and recipient mice.

Authors:  M Ogawa; Y Mori; T Mori; S Ueda; H Yoshida; I Kato; K Iesato; Y Wakashin; R Azemoto; M Wakashin
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

3.  Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis.

Authors:  H Löhr; M Manns; A Kyriatsoulis; A W Lohse; C Trautwein; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

4.  The IgG antibody reactivity of sera from patients with active chronic hepatitis to a crude liver antigen and liver specific protein (LSP): analysis by ELISA and immunoblotting.

Authors:  U Sundin; Z Heigl; K G Sundqvist
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

5.  Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment.

Authors:  R Wejstål; G Norkrans; O Weiland; R Schvarcz; D Fuchs; H Wachter; A Fryden; H Glaumann
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

6.  Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

Authors:  U M Zanger; H P Hauri; J Loeper; J C Homberg; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.

Authors:  D H Van Thiel; H Wright; P Carroll; K Abu-Elmagd; H Rodriguez-Rilo; J McMichael; W Irish; T E Starzl
Journal:  Am J Gastroenterol       Date:  1995-05       Impact factor: 10.864

8.  Occurrence of antibody against rat hepatic sinusoidal endothelial cells in sera of patients with autoimmune hepatitis.

Authors:  K Han; N Hashimoto; Y Ikeda; Y Shiratori; H Kato; G Toda; Y Komatsu; H Yamada; A Tanaka; K Kurokawa
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.